ETHOS II

Project Status: Current
People Involved: Carla Treloar, Jake Rance, Max Hopwood
Research Areas: Viral Hepatitis, Injecting Drug Use & Harm Reduction
Funding Agency: NSW Ministry of Health, NHMRC

Enhancing Treatment of Hepatitis C in Opioid Substitution Settings

This study aims to evaluate the impact of an intervention integrating non-invasive liver disease screening on HCV assessment and treatment in drug and alcohol clinics, and to develop a translational framework for subsequent establishment of HCV screening and treatment programs in the drug and alcohol setting across NSW and nationally.